-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MNrjd+Y3d3Qg9m4nKZsoTXjetvMVsr+A+1E3pi4lrKsmTPB15jAGlaAx/5K6NCPZ jrQYnV+BuSWMox5ES5FzoA== 0001247741-04-000062.txt : 20040603 0001247741-04-000062.hdr.sgml : 20040603 20040603151649 ACCESSION NUMBER: 0001247741-04-000062 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040601 FILED AS OF DATE: 20040603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MERTES TOD CENTRAL INDEX KEY: 0001234480 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20720 FILM NUMBER: 04847081 BUSINESS ADDRESS: STREET 1: C/O LIGAND PHARMACEUTICALS INC STREET 2: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585507577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 BUSINESS PHONE: 8585507500 MAIL ADDRESS: STREET 1: 10275 SCIENCE CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121-1117 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2004-06-01 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001234480 MERTES TOD 0 1 0 0 V-P, Controller & Treasurer Common Stock 2003-06-30 4 J 0 267 4.6495 A 1044 D Common Stock 2003-09-30 4 J 0 150 10.965 A 1194 D Common Stock 2003-12-31 4 J 0 152 10.8715 A 1346 D Common Stock 2004-03-31 4 J 0 130 12.6905 A 1476 D Employee Stock Option (right to buy) 20.7 2004-06-01 4 A 0 6358 A 2004-12-01 2014-06-01 Common Stock 6358 6358 D Employee Stock Option (right to buy) 20.7 2004-06-01 4 A 0 13642 A 2004-12-01 2014-06-01 Common Stock 13642 20000 D Shares acquired under Ligand's employee stock purchase plan being reported to update the securities beneficially owned by reporting person. No price applies. Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 6/1/04. By: Barbara J. Olson For: Tod G. Mertes 2004-06-03 -----END PRIVACY-ENHANCED MESSAGE-----